Browsing Norwegian Institute of Public Health Open Repository by Subject "Natalizumab"
Now showing items 1-2 of 2
-
Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment.
(Research report, 2019)Key message We have systematically collected and reviewed the evidence for clinical effectiveness and general safety issues for disease modifying treatments for relapsing remitting multiple sclerosis, synthesised evidence ... -
Natalizumab subkutant til behandling av relapserende remitterende multippel sklerose: forenklet metodevurdering– helseøkonomisk evaluering
(Research report, 2021)Hovedbudskap: Folkehelseinstituttet (FHI) har på oppdrag fra Bestillerforum for nye metoder utarbeidet en forenklet metodevurdering hvor den helseøkonomiske modellen i den fullstendige metodevurderingen om legemidler til ...